New Delhi: The trial of the Corona Vaccine Covishield of Oxford University AstraZeneca is being started once again in the country. In fact, Oxford University stopped the vaccine trial on 6 September. After this, on September 9, Serum also stopped his trial after DCGI's objection.
Oxford-AstraZeneca vaccine trial to resume soon
It is expected that after the re-trial of Oxford Vaccine Kovishield in the UK, it will start testing in India soon. The 'Serum Institute of India', which is preparing Oxford University's Kovishield in India, is awaiting the approval of the Drug Controller General of India (DCGI) to resume trials in the country. At the same time, DCGI is awaiting the approval of the Data Safety Monitoring Body.
France reports over 10000 cases in a single day
On this, the data safety monitoring body has questioned that the patient, after the illness, these trials were stopped, give information about them. The solution was demanded in that case. This body has sought details of people involved in the trial from the Seram Institute. Let me tell you that after the drug company AstraZeneca got the green signal from the British regulator, the human trial of the Corona vaccine has started once again.